Onkologie. 2020:14(2):96-99 | DOI: 10.36290/xon.2020.018

Selected frequent special palliative procedures in NSCLC

Martin Svatoň
Klinika pneumologie a ftizeologie, FN Plzeň a LF UK v Plzni

Treatment of non-small cell lung cancer is often associated with the need to treat some of the complicating factors associated with the disease. This article outlines the issues and solutions to the most commonly seen patient problems (except general cancer problems such as pain or malnutrition). Specifically, it deals with haemoptysis, upper vena cava syndrome, tumor airway obstruction, malignant effusions, respiratory insufficiency, thromboembolic diseases, hyponatraemia, hypercalcemia, bone and brain metastases. Its aim is to introduce the practical possibilities of solving these complications.

Keywords: non-small cell lung cancer, palliative procedures, symptomatic treatment.

Published: June 2, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Svatoň M. Selected frequent special palliative procedures in NSCLC. Onkologie. 2020;14(2):96-99. doi: 10.36290/xon.2020.018.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Skřičková J, Kolek V. Základy moderní pneumoonkologie. Praha: Maxdorf, 2012: 586s.
    2. Kolek V. Doporučené postupy v pneumologii. 2. aktualizované vydání. Praha: Maxdorf, 2009: 536s.
    3. Kašák V, Koblížek V. Naléhavé stavy v pneumologii. Praha: Maxdorf, 2009: 535s.
    4. Guimaraes MD, Bitencourt AG, Marchiori E, et al. Imaging acute complications in cancer patients: what should be evaluated in the emergency setting? Cancer Imaging 2014; 14(1): 18. Go to original source... Go to PubMed...
    5. Macha HN, Becker KO, Kemmer HP. Pattern of failure and survival in endobronchial laser resection. A matched pair study. Chest 1994; 105(6): 1668-1672. Go to original source... Go to PubMed...
    6. Stratakos G, Gerovasili V, Dimitropoulos C, et al. Survival and Quality of Life Benefit after Endoscopic Management of Malignant Central Airway Obstruction. J Cancer 2016; 7(7): 794-802. Go to original source... Go to PubMed...
    7. Schumann C, Hetzel M, Babiak AJ, et al. Endobronchial tumor debulking with a flexible cryoprobe for immediate treatment of malignant stenosis. J Thorac Cardiovasc Surg 2010; 139(4): 997-1000. Go to original source... Go to PubMed...
    8. Lee SH, Choi WJ, Sung SW, et al. Endoscopic cryotherapy of lung and bronchial tumors: a systematic review. Korean J Intern Med 2011; 26(2): 137-44. Go to original source... Go to PubMed...
    9. Khemasuwan D, Mehta AC, Wang KP. Past, present, and future of endobronchial laser photoresection. J Thorac Dis 2015; 7(Suppl 4): S380-388. Go to PubMed...
    10. Sachdeva A, Pickering EM, Lee HJ. From electrocautery, balloon dilatation, neodymium-doped:yttrium-aluminum-garnet (Nd:YAG) laser to argon plasma coagulation and cryotherapy. J Thorac Dis 2015; 7(Suppl 4): S363-379. Go to PubMed...
    11. Herth FJ, Eberhardt R. Airway stent: what is new and what should be discarded. Curr Opin Pulm Med 2016; 22(3): 252-256. Go to original source... Go to PubMed...
    12. Ranu H, Madden BP. Endobronchial stenting in the management of large airway pathology. Postgrad Med J 2009; 85(1010): 682-687. Go to original source... Go to PubMed...
    13. American Thoracic Society. Management of malignant pleural effusions. Am J Respir Crit Care Med 2000; 162(5): 1987-2001. Go to original source... Go to PubMed...
    14. Wilkes JD, Fidias P, Vaickus L, Perez RP. Malignancy-related pericardial effusion. 127 cases from the Roswell Park Cancer Institute. Cancer 1995; 76(8): 1377-1387. Go to original source...
    15. Macbeth F, Carter B, Noble S, Hood K. Further results of the FRAGMATIC trial of thromboprophylaxis in lung cancer. Transl Lung Cancer Res 2016; 5(3): 347-349. Go to original source... Go to PubMed...
    16. Grohé C, Berardi R, Burst V. Hyponatraemia - SIADH in lung cancer diagnostic and treatment algorithms. Crit Rev Oncol Hematol 2015; 96(1): 1-8. Go to original source... Go to PubMed...
    17. Svaton M, Fiala O, Pesek M, et al. Predictive and Prognostic Significance of Sodium Levels in Patients with NSCLC Treated by Erlotinib. Anticancer Res 2014; 34(12): 7461-7465.
    18. Mirrakhimov AE. Hypercalcemia of Malignancy: An Update on Pathogenesis and Management. N Am J Med Sci 2015; 7(11): 483-93. Go to original source... Go to PubMed...
    19. Manegold Ch. Non-small cell lung cancer treatment, 3rd edition. Bremen: UNI-MED-Verl, 2013. ISBN 978-1-84815-201-4.
    20. Novello S, Barlesi F, Califano R, et al. Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2016; 27(Suppl 5): v1-v27. Go to original source... Go to PubMed...
    21. Scagliotti GV, Hirsh V, Siena S, et al. Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study. J Thorac Oncol 2012; 7(12): 1823-1829. Go to original source... Go to PubMed...
    22. Yamamoto M, Serizawa T, Shuto T, et al. Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol 2014; 15(4): 387-95. Go to original source... Go to PubMed...
    23. Mulvenna P, Nankivell M, Barton R, et al. Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial. Lancet 2016; 388(10055): 2004-2014. Go to original source... Go to PubMed...
    24. Langley RE, Stephens RJ, Nankivell M, et al. Interim data from the Medical Research Council QUARTZ Trial: does whole brain radiotherapy affect the survival and quality of life of patients with brain metastases from non-small cell lung cancer? Clin Oncol (R Coll Radiol) 2013; 25(3): e23-30. Go to original source... Go to PubMed...
    25. Zer A, Moskovitz M, Hwang DM, et al. ALK-Rearranged Non-Small-Cell Lung Cancer Is Associated With a High Rate of Venous Thromboembolism. Clin Lung Cancer 2017; 18(2): 156-161. Go to original source... Go to PubMed...
    26. Koegelenberg CFN, Shaw JA, Irusen EM, Lee YCG. Contemporary best practice in the management of malignant pleural effusion. Ther Adv Respir Dis 2018; 12: 1753466618785098. Go to original source... Go to PubMed...

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.